πŸ‡ΊπŸ‡Έ FDA
Patent

US 10301323

Histone deacetylase inhibitors

granted A61PA61P21/00A61P21/02

Quick answer

US patent 10301323 (Histone deacetylase inhibitors) held by BIOMARIN PHARMACEUTICAL INC. expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P21/00, A61P21/02, A61P21/04, A61P25/00